Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poulam M Patel

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Anticancer Research|July 4, 2012
New anticancer immunotherapiesHester A Franks, Qunwei Wang, Poulam M Patel
Lymphatic Research and Biology|December 11, 2012
A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endotheliumSabreena Safuan, Sarah J Storr, Poulam M Patel, et al.
Immunotherapy|July 20, 2010
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancerAnton B Alexandroff, Steve Nicholson, Poulam M Patel, et al.
International Journal of Cancer|May 15, 2008
Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generationAndrew Mark Jackson, Lori Ann Mulcahy, Xing Wu Zhu, et al.
Cells|January 25, 2020
Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating GlioblastomaJason Adhikaree, Julia Moreno-Vicente, Aanchal Preet Kaur, et al.
Journal of Materials Chemistry. B|April 9, 2020
Immuno-silent polymer capsules encapsulating nanoparticles for bioimaging applicationsJaishree Jeyaraman, Anna Malecka, Poonam Billimoria, et al.
International Journal of Cancer|August 1, 2013
Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10Hester A Franks, Qunwei Wang, Stephanie J Lax, et al.
Melanoma Research|June 5, 2003
The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell lineDavid P Jackson, Diane Watling, Neil C Rogers, et al.
BMC Cancer|December 26, 2014
Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancerJillian Davis, Stewart G Martin, Poulam M Patel, et al.
Immunology|July 2, 2011
Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generationQunwei Wang, Hester A Franks, Joanne Porte, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Anticancer Research|July 4, 2012
New anticancer immunotherapiesHester A Franks, Qunwei Wang, Poulam M Patel
Lymphatic Research and Biology|December 11, 2012
A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endotheliumSabreena Safuan, Sarah J Storr, Poulam M Patel, et al.
Immunotherapy|July 20, 2010
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancerAnton B Alexandroff, Steve Nicholson, Poulam M Patel, et al.
International Journal of Cancer|May 15, 2008
Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generationAndrew Mark Jackson, Lori Ann Mulcahy, Xing Wu Zhu, et al.
Cells|January 25, 2020
Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating GlioblastomaJason Adhikaree, Julia Moreno-Vicente, Aanchal Preet Kaur, et al.
Journal of Materials Chemistry. B|April 9, 2020
Immuno-silent polymer capsules encapsulating nanoparticles for bioimaging applicationsJaishree Jeyaraman, Anna Malecka, Poonam Billimoria, et al.
International Journal of Cancer|August 1, 2013
Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10Hester A Franks, Qunwei Wang, Stephanie J Lax, et al.
Melanoma Research|June 5, 2003
The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell lineDavid P Jackson, Diane Watling, Neil C Rogers, et al.
BMC Cancer|December 26, 2014
Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancerJillian Davis, Stewart G Martin, Poulam M Patel, et al.
Immunology|July 2, 2011
Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generationQunwei Wang, Hester A Franks, Joanne Porte, et al.
Pageof 4